Tonight on Nightly Business Report, GlaxoSmithKline becomes the first major drug company to quit two of the industry's most common and controversial practices - the way it promotes its products and compensates its sales force. Will other companies follow? And, how is Congress spending your tax dollars? NBR has a list of projects one Senator calls "wasteful."